Pure Global

EUROLINE Anti-Gangliosides-Profile 2 - India CDSCO Medical Device Registration

EUROLINE Anti-Gangliosides-Profile 2 is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000152_fbc88ca04fa7e4df9378c06a48309eb6_efe1a2966625f8d2f2a027c8aef8910b. This device is marketed under the brand name NIL. The license holder is M/s. CPC Diagnostics Pvt Ltd, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
EUROLINE Anti-Gangliosides-Profile 2
UID: IMP/IVD/2022/000152_fbc88ca04fa7e4df9378c06a48309eb6_efe1a2966625f8d2f2a027c8aef8910b

Brand Name

NIL

Device Class

Class B

Approving Authority

CDSCO

Product Information

The EUROLINE test kit provides qualitative in vitro determination of human autoantibodies of the immunoglobulin class IgM to the seven gangliosides GM1, GM2, GM3, GD1a, GD1b, GT1b and GQ1b in serum or plasma to support the diagnosis of Guillain-Barre syndrome (NIL), chronic inflammatory demyelinating polyneuropathy (NIL), multifocal motor neuropathy (NIL), sensory neuropathy and Miller-Fisher syndrome (NIL)

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing